BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29421281)

  • 1. Antibody-mediated targeting of the transferrin receptor in cancer cells.
    Luria-Pérez R; Helguera G; Rodríguez JA
    Bol Med Hosp Infant Mex; 2016; 73(6):372-379. PubMed ID: 29421281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.
    Candelaria PV; Leoh LS; Penichet ML; Daniels-Wells TR
    Front Immunol; 2021; 12():607692. PubMed ID: 33815364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
    Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
    Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.
    Neiveyans M; Melhem R; Arnoult C; Bourquard T; Jarlier M; Busson M; Laroche A; Cerutti M; Pugnière M; Ternant D; Gaborit N; Chardès T; Poupon A; Gouilleux-Gruart V; Pèlegrin A; Poul MA
    MAbs; 2019 Apr; 11(3):593-605. PubMed ID: 30604643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
    Lee AW; Oates PS; Trinder D
    Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFBP-3/transferrin/transferrin receptor 1 complexes as principal mediators of IGFBP-3 delivery to colon cells in non-cancer and cancer tissues.
    Miljuš G; Malenković V; Đukanović B; Kolundžić N; Nedić O
    Exp Mol Pathol; 2015 Jun; 98(3):431-8. PubMed ID: 25839091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin receptor 1 in cancer: a new sight for cancer therapy.
    Shen Y; Li X; Dong D; Zhang B; Xue Y; Shang P
    Am J Cancer Res; 2018; 8(6):916-931. PubMed ID: 30034931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase.
    Shapiro JM; Chung W; Ogawa K; Barker L; Carlson R; Wands JR; Li J
    PLoS One; 2016; 11(11):e0165227. PubMed ID: 27802297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chrono-drug delivery system based on the circadian rhythm of transferrin receptor].
    Matsunaga N; Okazaki F; Koyanagi S; Ohdo S
    Nihon Rinsho; 2013 Dec; 71(12):2200-5. PubMed ID: 24437279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis.
    Waheed A; Grubb JH; Zhou XY; Tomatsu S; Fleming RE; Costaldi ME; Britton RS; Bacon BR; Sly WS
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3117-22. PubMed ID: 11867720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.
    Leoh LS; Daniels-Wells TR; Martínez-Maza O; Penichet ML
    Mol Immunol; 2015 Oct; 67(2 Pt B):407-15. PubMed ID: 26232328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation.
    Jeong SM; Hwang S; Seong RH
    Biochem Biophys Res Commun; 2016 Mar; 471(3):373-9. PubMed ID: 26869514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Hfe in transferrin-bound iron uptake by hepatocytes.
    Chua AC; Herbison CE; Drake SF; Graham RM; Olynyk JK; Trinder D
    Hepatology; 2008 May; 47(5):1737-44. PubMed ID: 18393371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice.
    Okazaki F; Matsunaga N; Okazaki H; Utoguchi N; Suzuki R; Maruyama K; Koyanagi S; Ohdo S
    Cancer Res; 2010 Aug; 70(15):6238-46. PubMed ID: 20631077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Analysis of Transferrin Receptor 1 (TfR1) in Individual Breast Cancer Cells by Means of Labeled Antibodies and Elemental (ICP-MS) Detection.
    Corte-Rodríguez M; Blanco-González E; Bettmer J; Montes-Bayón M
    Anal Chem; 2019 Dec; 91(24):15532-15538. PubMed ID: 31694367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway.
    Song X; Yu H; Sullenger C; Gray BP; Yan A; Kelly L; Sullenger B
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor-1 suppresses neurite outgrowth in neuroblastoma Neuro2A cells.
    Nakamura Y; Nakamichi N; Takarada T; Ogita K; Yoneda Y
    Neurochem Int; 2012 Apr; 60(5):448-57. PubMed ID: 22019713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of glyceraldehyde-3-phosphate dehydrogenase as a novel transferrin receptor.
    Kumar S; Sheokand N; Mhadeshwar MA; Raje CI; Raje M
    Int J Biochem Cell Biol; 2012 Jan; 44(1):189-99. PubMed ID: 22062951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transferrin receptor 2 in human cancer cell lines.
    Calzolari A; Finisguerra V; Oliviero I; Deaglio S; Mariani G; Malavasi F; Testa U
    Blood Cells Mol Dis; 2009; 42(1):5-13. PubMed ID: 19019709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing in vitro affinity measurements of antibodies to TfR1: Surface plasmon resonance versus on-cell affinity.
    Bonvicini G; Bagawath Singh S; Nygren P; Xiong M; Syvänen S; Sehlin D; Falk R; Andersson KG
    Anal Biochem; 2024 Mar; 686():115406. PubMed ID: 38006952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.